129 related articles for article (PubMed ID: 3162290)
1. [Correlation between the levels of CA 19-9 and Ca-50 in colorectal cancer].
Lamíquiz Vallejo A; Domínguez Merru-Urrutia MJ; Loizate Totoricagüena A; Cruz Fombellida Cortázar J
Med Clin (Barc); 1988 Jan; 90(1):42. PubMed ID: 3162290
[No Abstract] [Full Text] [Related]
2. [Clinical significance of the determination of serum carbohydrate antigen 19-9 in patients with carcinoma of the stomach and colorectum].
Hamazoe R; Yoshioka H; Furumoto T; Kanayama H; Shimizu N; Maeta M; Koga S
Gan No Rinsho; 1985 Aug; 31(10):1287-92. PubMed ID: 3863968
[TBL] [Abstract][Full Text] [Related]
3. [Colorectal neoplasms: preoperative determination of GICA].
Bussone R; Sanlorenzo M; Natta F; Rocca N; Caldarola B
Minerva Chir; 1987 Oct; 42(20):1655-6. PubMed ID: 3479706
[No Abstract] [Full Text] [Related]
4. [Preoperative determination of carcinoembryonic antigen and gastrointestinal antigen in neoplastic colorectal pathology. Case contributions].
Ramella A; Bussone R; Sanlorenzo M; Natta F; Caldarola B; Schirripa C; Giani R; Pecchio F; Rocca N
Minerva Chir; 1987 Jun; 42(12):1037-43. PubMed ID: 3476864
[No Abstract] [Full Text] [Related]
5. Carcinoembryonic antigen in prognosis of colorectal cancer.
N Engl J Med; 1978 Dec; 299(24):1369-70. PubMed ID: 714113
[No Abstract] [Full Text] [Related]
6. Evaluation of Ca 12-5 as a tumor marker for gastric and colo-rectal cancer in comparison to CEA and Ca 19-9.
Quentmeier A; Schlag P; Geisen HP; Schmidt-Gayk H
Eur J Surg Oncol; 1987 Jun; 13(3):197-201. PubMed ID: 3474158
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues.
Itzkowitz SH; Yuan M; Fukushi Y; Lee H; Shi ZR; Zurawski V; Hakomori S; Kim YS
Cancer Res; 1988 Jul; 48(13):3834-42. PubMed ID: 3288336
[TBL] [Abstract][Full Text] [Related]
8. [Value of CA 19-9 in tumor after-care in stomach and colorectal cancer].
Safi F; Rappenecker B; Roscher R; Beger HG
Med Klin (Munich); 1986 Jan; 81(1):12-4. PubMed ID: 3466002
[No Abstract] [Full Text] [Related]
9. [Tumor antigens CA 125 and CA l9-9 in the serum of patients with gynecologic trophoblastic tumors and colorectal carcinoma].
Göcze P; Szabó D; Than G; Csaba I; Krommer K
Orv Hetil; 1986 Aug; 127(35):2123-6. PubMed ID: 3024089
[No Abstract] [Full Text] [Related]
10. The role of tumour markers (CEA, TPA, CA 19-9) in colon and rectum carcinomas.
Cangemi V; Volpino P; Fiori E; Giammarco A; Piat G
J Nucl Med Allied Sci; 1987; 31(2):189-93. PubMed ID: 3476692
[No Abstract] [Full Text] [Related]
11. The clinical significance of serum CA 19-9 in patients with gastric and colorectal carcinoma and immunohistochemical visualization of CA 19-9 in tumor tissues.
Sekikawa K
Fukushima J Med Sci; 1985 Jun; 31(1):29-42. PubMed ID: 3866740
[No Abstract] [Full Text] [Related]
12. [Prognostic value of postoperative determination of CEA in carcinoma of the large intestine].
Florianello F; Gorla C; Biraghi T; Caron R; Scortecci V
Minerva Med; 1986 Apr; 77(18):739-41. PubMed ID: 3714087
[TBL] [Abstract][Full Text] [Related]
13. [Expression of CA 19-9 in tubular and tubulovillous adenomas of the descending and sigmoid colon and the rectum with respect to morphologic differentiation characteristics and the adenoma-carcinoma sequence].
Capek P; Jirásek A; Fric P; Dvoráková H
Sb Lek; 1990 May; 92(5):129-34. PubMed ID: 2371529
[TBL] [Abstract][Full Text] [Related]
14. [The role of immunologic markers in the diagnosis and monitoring of large-intestinal neoplasms].
Harłozińska-Szmyrka A
Pol Arch Med Wewn; 1992; 88(2-3):181-9. PubMed ID: 1492024
[No Abstract] [Full Text] [Related]
15. Significance of measurement of a carbohydrate antigenic determinant 19-9 (CA 19-9) for monitoring colorectal cancer patients.
Tomoda H; Furusawa M
Jpn J Surg; 1986 Jan; 16(1):73-5. PubMed ID: 2421035
[TBL] [Abstract][Full Text] [Related]
16. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
Muhrer KH; Kahle M; Pasurka B
Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
[TBL] [Abstract][Full Text] [Related]
17. [Importance of CEA determination in colo-rectal neoplasms].
Pezcoller C; Ricchi E; Briccoli A; Saviano MS; Ferrara F; De Palma M; Guernelli N
Minerva Chir; 1984 Feb; 39(3):153-60. PubMed ID: 6728213
[No Abstract] [Full Text] [Related]
18. [Carcinoembryonic antigen, CEA, in colorectal cancer. An insensitive marker which may be excluded from follow-ups].
Wählby L
Lakartidningen; 1997 Apr; 94(18):1716-8. PubMed ID: 9182180
[No Abstract] [Full Text] [Related]
19. A clinical study of CA-50 as a tumour marker for monitoring of colorectal cancer.
Persson BE; Ståhle E; Påhlman L; Glimelius B; Nilsson O; Lindholm L; Norrgård-Pedersen B; Holmgren J
Med Oncol Tumor Pharmacother; 1988; 5(3):165-71. PubMed ID: 3166084
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative elevation of CEA, CA 19-9 and CA 50 in the inoperable stages of colorectal cancer].
Lamíquiz Vallejo A; Loizate Totoricagüena A; Domínguez Merru-Urrutia MJ
Rev Esp Enferm Apar Dig; 1988 Mar; 73(3):323-4. PubMed ID: 2453075
[No Abstract] [Full Text] [Related]
[Next] [New Search]
